Oncolytics Biotech (ONCY) Amortization - Intangibles (2009 - 2010)
Oncolytics Biotech's (ONCY) quarterly Amortization - Intangibles came in at $3.6 million in Q3 2010, up 200.0% year-on-year from $1.2 million in Q3 2009, and little changed on a QoQ basis from $3.6 million in Q2 2010.
Oncolytics Biotech (ONCY) Amortization - Intangibles (2009 - 2010) Analysis & Trends
Oncolytics Biotech (ONCY) has 2 years of Amortization - Intangibles data on file, last reported at $3.6 million in Q3 2010.
- On a quarterly basis, Amortization - Intangibles rose 200.0% year-over-year to $3.6 million in Q3 2010; TTM through Dec 2010 was $3.6 million, a 200.0% increase from a year earlier, with the FY2010 full-year figure at $3.6 million, up 1900.0% from the prior year.
- Amortization - Intangibles for Q3 2010 stood at $3.6 million, roughly flat from $3.6 million in the prior quarter.
- Over the last five years, Amortization - Intangibles for ONCY reached as high as $3.6 million in Q2 2010 and fell as low as -$3.6 million in Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 3.62 Mn |
| Jun 30, 2010 | 3.62 Mn |
| Mar 31, 2010 | -3.62 Mn |
| Sep 30, 2009 | -3.62 Mn |
| Jun 30, 2009 | 90,375.00 |
| Mar 31, 2009 | -90,375.00 |